Search in:

Advanced search

OncoTargets and Therapy Volume 6, 2013 - Issue

Submit an article Journal homepage

Open access

204

Views

CrossRef citations to date

Altmetric

Original Research

454 next generation-sequencing outperforms allele-specific PCR, Sanger sequencing, and pyrosequencing for routine KRAS mutation analysis of formalin-fixed, paraffin-embedded samples

Annalisa Altimari1 Laboratory of Molecular Oncologic and Transplantation Pathology, S. Orsola-Malpighi Hospital, Bologna, Italy

Dario de Biase2 Laboratory of Molecular Pathology, Anatomic Pathology, Bellaria Hospital, Bologna, Italy

Giovanna De Maglio3 Department of Pathology, S. Maria della Misericordia Hospital, Udine, Italy

Elisa Gruppioni1 Laboratory of Molecular Oncologic and Transplantation Pathology, S. Orsola-Malpighi Hospital, Bologna, Italy

Elisa Capizzi1 Laboratory of Molecular Oncologic and Transplantation Pathology, S. Orsola-Malpighi Hospital, Bologna, Italy

Alessio Degiovanni1 Laboratory of Molecular Oncologic and Transplantation Pathology, S. Orsola-Malpighi Hospital, Bologna, Italy

Antonia D’Errico1 Laboratory of Molecular Oncologic and Transplantation Pathology, S. Orsola-Malpighi Hospital, Bologna, Italy

Annalisa Pession2 Laboratory of Molecular Pathology, Anatomic Pathology, Bellaria Hospital, Bologna, Italy

Stefano Pizzolitto3 Department of Pathology, S. Maria della Misericordia Hospital, Udine, Italy

Michelangelo Fiorentino1 Laboratory of Molecular Oncologic and Transplantation Pathology, S. Orsola-Malpighi Hospital, Bologna, ItalyCorrespondence[email protected]

Giovanni Tallini2 Laboratory of Molecular Pathology, Anatomic Pathology, Bellaria Hospital, Bologna, Italy

show all

Pages 1057-1064 | Published online: 05 Aug 2013

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

Van CutsemEKöhneCHHitreECetuximab and chemotherapy as initial treatment for metastatic colorectal cancerN Engl J Med20093601408141719339720
PubMed Web of Science ®Google Scholar
BanckMSGrotheyABiomarkers of resistance to epidermal growth factor receptor monoclonal antibodies in patients with metastatic colorectal cancerClin Cancer Res2009157492750120008849
PubMed Web of Science ®Google Scholar
Van CutsemELangID’HaensGKRAS status and efficacy in the first-line treatment of patients with metastatic colorectal cancer (mCRC) treated with FOLFIRI with or without cetuximab: the CRYSTAL experienceJ Clin Oncol200826Suppl 2 Abstr 2
Google Scholar
BokemeyerCBondarenkoIHartmannJTEfficacy according to bio-marker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS studyAnn Oncol2011221535154621228335
PubMed Web of Science ®Google Scholar
DahabrehIJTerasawaTCastaldiPJTrikalinosTSystematic review: anti-epidermal growth factor receptor treatment effect modification by KRAS mutations in advanced colorectal cancerAnn Intern Med2011154374921200037
PubMed Web of Science ®Google Scholar
Van CutsemEKöhneCHLángICetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation statusJ Clin Oncol2011292011201921502544
PubMed Web of Science ®Google Scholar
AmadoRGWolfMPeetersMWild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancerJ Clin Oncol2008261626163418316791
PubMed Web of Science ®Google Scholar
JimenoAMessersmithWAHirschFRFranklinWAEckhardtSGKRAS mutations and sensitivity to epidermal growth factor receptor inhibitors in colorectal cancer: practical application of patient selectionJ Clin Oncol2009271130113619124802
PubMed Web of Science ®Google Scholar
GaoJLiYYSunPNShenLComparative analysis of dideoxy sequencing, the KRAS strip assay and pyrosequencing for detection of KRAS mutationWorld J Gastroenterol2010164858486420939116
PubMed Web of Science ®Google Scholar
SundströmMEdlundKLindellMKRAS analysis in colorectal carcinoma: analytical aspects of pyrosequencing and allele-specific PCR in clinical practiceBMC Cancer20101066066921122130
PubMed Web of Science ®Google Scholar
FranklinWAHaneyJSugitaMBemisLJimenoAMessersmithWAKRAS mutation: comparison of testing methods and tissue sampling techniques in colon cancerJ Mol Diagn201012435020007845
PubMed Web of Science ®Google Scholar
BihlMPHoellerSAndreozziMCKRAS mutations testing in colorectal cancer: comparison of the results obtained using 3 different methods for the analysis of codons G12 and G13Diagn Mol Pathol201221142322306671
PubMed Web of Science ®Google Scholar
FrenchDSmithAPowersMPWuAHKRAS mutation detection in colorectal cancer by a commercially available gene chip array compares well with Sanger sequencingClin Chim Acta20114121578158121575616
PubMed Web of Science ®Google Scholar
LeeSBrophyVHCaoJAnalytical performance of a PCR assay for the detection of KRAS mutations (codons 12/13 and 61) in formalin-fixed paraffin-embedded tissue samples of colorectal carcinomaVirchows Arch201246014114922173329
PubMed Web of Science ®Google Scholar
Gonzalez de CastroDAnguloBGomezBA comparison of three methods for detecting KRAS mutations in formalin-fixed colorectal cancer specimensBr J Cancer201210734535122713664
PubMed Web of Science ®Google Scholar
RonaghiMUhlénMNyrénPA sequencing method based on real-time pyrophosphateScience19982813633659705713
PubMed Web of Science ®Google Scholar
CrossJDxS LtdPharmacogenomics2008946346718384259
PubMed Web of Science ®Google Scholar
Autogenomics.com [homepage on the Internet]Autogenomics Inc.http://www.autogenomics.com/cancer_KRAS-BRAF.php Available from: http://www.autogenomics.com/Accessed June 18, 2013
Google Scholar
454.com. 454.com [homepage on the Internet]454 Life Sciences, a Roche Companyhttp://454.com/downloads/GSJuniorSystem_Brochure.pdf Available from: http://www.454.com/Accessed June 18, 2013
Google Scholar
Aiom.it [homepage on the Internet]Associazione Italiana di Oncologia Medicahttp://www.aiom.it/area+pubblica/area+medica/prodotti+scientifici/position+paper/Raccomandazioni%20per%20l'analisi%20mutazionale%20del%20gene%20KRAS%20nel%20carcinoma%20del%20colon-retto/1,1006,1 Available from: http://www.Aiom.it/Accessed June 18, 2013
Google Scholar
van KriekenJHJungAKirchnerTKRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance programVirchows Arch200845341743118802721
PubMed Web of Science ®Google Scholar
HosteinILamyAFaurNThe detection of double mutations in KRAS depends on the mutation-detection assay usedClin Chem2011571077107921441420
PubMed Web of Science ®Google Scholar
ZhouQZhangXCChenZHRelative abundance of EGFR mutations predicts benefit from Gefitinib treatment for advanced non small cell lung cancerJ Clin Oncol2011293316332121788562
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

454 next generation-sequencing outperforms allele-specific PCR, Sanger sequencing, and pyrosequencing for routine KRAS mutation analysis of formalin-fixed, paraffin-embedded samples

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

454 next generation-sequencing outperforms allele-specific PCR, Sanger sequencing, and pyrosequencing for routine KRAS mutation analysis of formalin-fixed, paraffin-embedded samples

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date